Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients whom investigators have decided to treat with Lanthanum carbonate for the first time at the respective medical institutions. Those medical institutions have to understand the objective of this investigation and conclude a written contract with Bayer Yakuhin.
The decision to treat patients with Lanthanum carbonate will be made independently by the investigator prior to study inclusion.
Patients treated with Lanthanum carbonate in the indication "Hyperphosphatemia" with chronic kidney disease not on dialysis".
You may not be if
Patients who are contraindicated based on the product label.
Patients who have been already treated with Fosrenol
